Aspergillus fischeri var. brasiliensis Karwowski et al., anamorph
商品貨號
B203239
Strain Designations
AB 1826M-35 [NRRL 18896]
Application
produces 5-N-acetylardeemin
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Type Strain
no
Preceptrol®
no
Medium
ATCC® Medium 325: Malt extract agar (Blakeslee's formula)
Growth Conditions
Temperature: 37.0°C
Sequenced Data
No DNA sequencing was performed in house on this product.
Name of Depositor
Abbott Labs.
Special Collection
NCRR Contract
Chain of Custody
ATCC <<--Abbott Labs.<<--P. Humphrey
Isolation
soil, Brazil
References
Kadam SK, et al. Multiple drug resistance-attenuating compounds. US Patent 5,284,947 dated Feb 8 1994
Karwowski JP, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. I. Taxonomy and fermentation of the producing organism and biological activity. J. Antibiot. 46: 374-379, 1993. PubMed: 8478255
Hochlowski JE, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners. J. Antibiot. 46: 380-386, 1993. PubMed: 8478256
